Branded Generics Market Is Projected To Grow Exponentially As Large Number Of New Pharmaceutical Products Till 2025: Grand View Research, Inc.

February 22 16:30 2017

Grand View Research, Inc. – Market Research And Consulting.
According to new report by Grand View Research, The global branded generics market is projected to grow gradually as large number of pharmaceutical products are going to go off patent within the forecast period of 2014 to 2025.

Branded drugs are patented drugs. When a pharmaceutical company discovers a new drug, it files for a patent. Branded generics are generic versions of products sold either by the original manufacturer of the patented drug or by generic manufacturers that build up brand equity for their generic versions of the medication, which they introduce right after the patent expires on the original product.

Access research report on Branded Generics Market Analysis: http://www.grandviewresearch.com/industry-analysis/branded-generics-market

The global branded generics market is projected to grow gradually as large number of pharmaceutical products are going to go off patent within the forecast period of 2014 to 2025. The global branded generics market is predictable to grow significantly as large number of pharmaceutical products are going to be off patent within the forecast period.

Trade (Brand) Named Generics are the ones that have one or more brand names. Several companies may make the same generic medicine, each with their own brand name. On the basis of application, the global market size spans Cardiovascular Drugs, Anti-Cancer Drugs, CNS Drugs, Anti-Infective Drugs, Others.

Browse Related Reports

•    Cell Harvesting Systems Market – http://www.grandviewresearch.com/industry-analysis/cell-harvesting-systems-market
    Chemotherapy Induced Anemia Market – http://www.grandviewresearch.com/industry-analysis/chemotherapy-induced-anemia-market

Cardiovascular Drugs form the most rapidly growing market for branded generic drugs. The main contribution towards this regard has been provided by the expiry of patents of most of CVS drugs. CNS Drugs segment is expected to grow during the forecast period of 2014 to 2025, this is due to the rapid growth patent expiry of several key anti psychotics and antidepressants.

The key players of the global market size are Teva Pharmaceutical Industries Ltd, Mylan N.V., Hospira Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., GlaxoSmithKline Pharmaceuticals Limited, Valeant, ZydusCadila, Sandoz, Lupin Pharmaceuticals, Inc. Par Pharmaceutical Companies, Inc., Sanofi, and AstraZeneca.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/branded-generics-market

  Categories: